Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis

BACKGROUND: Genetic testing is moving from targeted investigations of monogenetic diseases to broader testing that may provide more information. For example, recent health economic studies of genetic testing for an increased risk of breast cancer suggest that it is associated with higher cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustavsson, Erik, Galvis, Giovanni, Juth, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579789/
https://www.ncbi.nlm.nih.gov/pubmed/33087101
http://dx.doi.org/10.1186/s12910-020-00545-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579789/
https://www.ncbi.nlm.nih.gov/pubmed/33087101
http://dx.doi.org/10.1186/s12910-020-00545-8

Ejemplares similares